Watchlist

Watchlist
Valeant Pharmaceuticals Internation... (VRX)
Valeant Pharmaceuticals Internation... (VRX)
FDA launches new program to boost transparency of clinical data used to support approvals
Aimed at improving the transparency of its drug approvals, the FDA launches a pilot program under which it will post certain information contained in clinical study reports (CSRs) on its website. The agency hopes the additional data will make it easier for stakeholders to access and unders…
Worst Year Ever: Bill Ackman Or Eddie Lampert?
Worst Year Ever: Bill Ackman or Eddie Lampert? Answer: It's a toss up Bill Ackman has continued to suffer loss after loss with his investments: Valeant Pharmaceuticals (VRX) got crushed, Chipotle Mexican Grill (CMG) got crushed, and Herbalife (HLF), his much hyped up short, has doubled. In…
SA Interview: Healthcare Investing With Paul Nouri, CFP
Feature interview Paul Nouri, CFP , manages the Noble Equity Fund, a healthcare-focused hedge fund and manages Noble Advisors, a RIA. We emailed with Paul about how activist investing has changed in the healthcare sector, two notable examples of how a shareholder letter played out and wha…
Your Daily Pharma Scoop: Lipocine's Gloomy Future, Puma Labeling Change, Concert's Mixed Day
Today we will discuss the Ad Com's vote against Lipocine's ( LPCN ) TLANDO. The news sparked a huge sell-off in LPCN on Wednesday. Few days before the Ad Com, we had written a note on LPCN, highlighting that it is a binary event. TLANDO had been rejected by the FDA in 2016, which pushed LPCN…
Buy Pershing Square At A 25% Discount To Net Asset Value
Pershing Square Holdings ( PSHZF ) trades at a ~25% discount to net asset value, or NAV, on both the Amsterdam and the London stock exchanges. Pershing Square Holdings is a permanent capital vehicle managed by the famous activist Bill Ackman. Over 2017 Pershing Square achieved -2.7%, which is …
FDA accepts Ortho Dermatologics' NDA for IDP-121 acne treatment in lotion form
Ortho Dermatologics, a division of Valeant Pharmaceuticals (NYSE: VRX ) announces that the FDA has accepted its New Drug Application for IDP-121 (tretinoin 0.05%) lotion (ALTRENO) with an action date of August 27. More news on: Valeant Pharmaceuticals International, Inc., Healthcare stoc…
Ortho Dermatologics Announces U.S. FDA Filing Acceptance For IDP-121 Acne Treatment In Lotion Form
PDUFA Date Is Aug. 27, 2018 LAVAL, Quebec , Jan. 12, 2018 /PRNewswire/ --Ortho Dermatologics, a division of Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") , today announced that the U.S. Food and Drug Administration (FDA) has accepted the New …
Valeant: What Does Papa's New Promise Mean For The Company?
Valeant Pharmaceuticals International Inc. ( VRX ) is a guest at the Annual J.P. Morgan Healthcare Conference in San Francisco where CEO Joseph C. Papa will provide an update for the company. Last February Papa delivered a promise to reduce Valeant's debt load by $5 billion by February's upcom…
Valeant Pharmaceuticals (VRX) Presents At 36th Annual J.P. Morgan Healthcare Conference - Slideshow
The following slide deck was published by Valeant Pharmaceuticals International, Inc. in conjunction with this Read more …
Valeant presentation at JPM18 set for tomorrow at 1:30 ET; shares up 3%
Valeant Pharmaceuticals ( VRX +3.2% ) chief Joseph Papa will deliver a corporate overview at JPM18 tomorrow, January 10, at 1:30 pm ET (10:30 am PT). Key points: More news on: Valeant Pharmaceuticals International, Inc., Healthcare stocks news, Stocks on the move, Read more …
How I Beat The Market Again In 2017
A year ago I posted my first annual summary of investment performance on Seeking Alpha, and with this article I document the latest chapter in my now seven-year history as an individual investor. As before, the focus will be on my single stock picks, but Ill briefly summarize my activi…
Valeant Pharmaceuticals Internation... (VRX)
Valeant Pharmaceuticals Internation... (VRX)